www.palliativedrugs.com PCF updated website monographs (since PCF5 publication) November 2014 to September 2017 Monograph Chapter number Date updated Oral nutritional supplements Chapter 29 Correction Nov-14 Antihistaminic antimuscarinic anti-emetics Chapter 04 Minor change Feb-15 QCG: Vertigo Chapter 04 New Feb-15 Urinary tract infections Chapter 06 Minor change Feb-15 Corticosteroids (systemic) Chapter 07 Minor change Apr-15 Prolongation of the QT interval in palliative care Chapter 24 Minor change Apr-15 Propofol Chapter 13 Minor change Apr-15 Strong opioids Chapter 05 Apr-15 Antacids Chapter 01 May-15 Compound alginate products Chapter 01 May-15 Drugs and fitness to drive Chapter 19 May-15 Oral nutritional supplements Chapter 29 May-15 Products for haemorrhoids Chapter 01 May-15 Simeticone Chapter 01 May-15 Variability in response to drugs Chapter 25 May-15 Zinc Chapter 09 May-15 Fentanyl (transmucosal) Chapter 05 Jun-15 Ketamine Chapter 13 Jun-15 Ascorbic acid Chapter 09 Jul-15 Catheter Patency solutions Chapter 08 Jul-15 Discoloured urine Chapter 08 Jul-15 Pancreatin Chapter 01 Jul-15 Potassium Chapter 09 Jul-15 Rectal products for constipation Chapter 01 Jul-15 Antimuscarinics Chapter 01 Minor change Aug-15 H2-receptor antagonists Chapter 01 Aug-15 Misoprostol Chapter 01 Discontinued Aug-15 Phenobarbital Chapter 04 Minor change Aug-15 Proton pump inhibitors Chapter 01 Aug-15 Anti-emetics Chapter 04 Minor change Nov-15 Guidance about prescribing in palliative care Chapter 14 Correction Nov-15 Levomepromazine Chapter 04 Minor change Nov-15 Prolongation of the QT interval in palliative care Chapter 24 Minor change Nov-15 Rifampicin Chapter 06 New Nov-15 Benzodiazepines Chapter 04 Correction Jan-16 Cellulitis in a lymphoedematous limb Chapter 06 Jan-16 QCG: Cellulitis in lymphoedema Chapter 06 Jan-16 Opioid dose conversion ratios Chapter 15 Minor change Mar-16 QCG: Use of transdermal buprenorphine patches Chapter 05 Minor change Mar-16 Progestogens Chapter 07 Apr-16 Opioid antagonists Chapter 05 Minor change May-16 Furosemide Chapter 02 Jun-16 Prolongation of the QT interval in palliative care Chapter 24 Minor change Jun-16 Proton pump inhibitors Chapter 01 Minor change Jul-16 Antihistaminic antimuscarinic anti-emetics Chapter 04 Minor change Aug-16 Corticosteroids (systemic) Chapter 07 Minor change Aug-16 Danazol Chapter 07 Aug-16 Demeclocycline Chapter 07 Aug-16 Desmopressin Chapter 07 Aug-16 H2-receptor antagonists Chapter 01 Minor change Aug-16 Haemostatics Chapter 02 Aug-16 Helicobacter pylori gastritis Chapter 06 Discontinued Aug-16 Laxatives Chapter 01 Minor change Aug-16 Morphine Chapter 05 Minor change Aug-16 www.palliativedrugs.com September 2017 www.palliativedrugs.com PCF updated website monographs continued Monograph Chapter number Date updated Paracetamol Chapter 05 Aug-16 Propofol Chapter 13 Aug-16 QCG: Death rattle (noisy rattling breathing) Chapter 01 Aug-16 QCG: Opioid-induced constipation Chapter 01 Aug-16 Skeletal muscle relaxants Chapter 10 Minor change Aug-16 Anti-emetics Chapter 04 Minor change Sep-16 Systemic local anaesthetics Chapter 02 Nov-16 Antibacterials Chapter 06 Feb-17 Cardiovascular Introduction Chapter 02 Feb-17 Opioid antagonists Chapter 05 Discontinued Feb-17 Opioid antagonists (outside CNS) Chapter 05 New Feb-17 Opioid antagonists (within CNS) Chapter 05 New Feb-17 Spironolactone Chapter 02 Feb-17 Anaphylaxis Appendix 01 (new) Mar-17 Anticipatory prescribing Chapter 15 (new) Mar-17 Drugs and fitness to drive Chapter 22 (new) Mar-17 Obtaining specials Chapter 24 (new) Mar-17 QCG: Respiratory depression Chapter 05 New Mar-17 Taking controlled drugs abroad Chapter 23 (new) Mar-17 Use of medicinal products beyond (off-label) and without a Prelims Mar-17 marketing authorization Baclofen Chapter 10 Apr-17 Cerumenolytics Chapter 11 Apr-17 Clostridium difficile infection Chapter 06 Apr-17 Compatibility charts Appendix 03 Apr-17 Continuous subcutaneous drug infusions Chapter 29 (new) Apr-17 Drug administration to patients with swallowing difficulties Chapter 28 (new) Apr-17 and EFT Drug-induced movement disorders Chapter 21 (new) Apr-17 Drugs for prutitus Chapter 26 (new) Apr-17 Management of post op pain Chapter 25 (new) Apr-17 Mouthwashes Chapter 11 Apr-17 Nebulized drugs Chapter 31 (new) Apr-17 Opioid dose conversion ratios Appendix 02 (new) Apr-17 Oral nutritional supplements Chapter 27 (new) Apr-17 Prescribing for children Chapter 16 (new) Apr-17 Prescribing in palliative care Chapter 14 (new) Apr-17 Prolongation of the QT interval in palliative care Chapter 20 (new) Renumbered only Apr-17 Renal impairment Chapter 17 (new) New Apr-17 Skeletal muscle relaxants Chapter 10 Apr-17 Spinal analgesia Chapter 32 (new) Apr-17 Strong opioids Chapter 05 Minor change Apr-17 Transdermal patches Chapter 30 (new) New Apr-17 Variability in response to drugs Chapter 19 (new) Renumbered only Apr-17 Dantrolene Chapter 10 Jun-17 Pilocarpine Chapter 11 Jun-17 QCG: Death rattle (noisy rattling breathing) Chapter 01 Jun-17 Simeticone Chapter 01 Minor change Jun-17 Tizanidine Chapter 10 Jun-17 Antimuscarinics Chapter 01 Jul-17 Antitussives Chapter 03 Jul-17 Bronchodilators Chapter 03 Jul-17 Demeclocycline Chapter 07 Minor change Jul-17 Drugs for cough Chapter 03 Jul-17 Glycopyrronium Chapter 01 Jul-17 www.palliativedrugs.com September 2017 2 of 5 www.palliativedrugs.com PCF updated website monographs continued Monograph Chapter number Date updated Hepatic impairment Chapter 18 (new) New Jul-17 Hyoscine butylbromide Chapter 01 Jul-17 Hyoscine hydrobromide Chapter 01 Jul-17 Inhaled long-acting beta2 agonsits (LABAs) Chapter 03 Jul-17 Ipratropium Chapter 03 Jul-17 Ispaghula (psyllium) husk Chapter 01 Jul-17 Loperamide Chapter 01 Jul-17 Mucolytics Chapter 03 Jul-17 Oral candidosis Chapter 06 Jul-17 Orphenadrine Chapter 01 Jul-17 Oxygen Chapter 03 Jul-17 Propantheline Chapter 01 Jul-17 Salbutamol Chapter 03 Jul-17 Skeletal muscle relaxants Chapter 10 Minor change Jul-17 Theophylline Chapter 03 Jul-17 Tiotropium Chapter 03 Jul-17 Anticoagulants Chapter 02 Aug-17 Benzodiazepines and Z-drugs Chapter 04 Aug-17 Clonazepam Chapter 04 Discontinued Aug-17 Clonidine Chapter 02 Aug-17 Depot corticosteroids Chapter 10 Minor change Aug-17 Desmopressin Chapter 07 Aug-17 Diazepam Chapter 04 Discontinued Aug-17 Docusate sodium Chapter 01 Aug-17 Glyceryl trinitrate Chapter 02 Aug-17 Inhaled corticosteroids Chapter 03 Aug-17 Ketamine Chapter 13 Aug-17 Lactulose Chapter 01 Aug-17 Laxatives Chapter 01 Aug-17 LMWH Chapter 02 Aug-17 Lorazepam Chapter 04 Discontinued Aug-17 Macrogols Chapter 01 Aug-17 Magnesium salts Chapter 01 Aug-17 Melatonin Chapter 04 Aug-17 Methenamine hippurate Chapter 08 Minor change Aug-17 Metronidazole Chapter 06 Aug-17 Midazolam Chapter 04 Discontinued Aug-17 Nifedipine Chapter 02 Aug-17 Opioid dose conversion ratios Appendix 02 (new) Minor change Aug-17 Oxybutynin Chapter 08 Aug-17 Phytomenadione Chapter 09 Minor change Aug-17 Prokinetics Chapter 01 Aug-17 Psychotropics Chapter 04 Discontinued Aug-17 QCG: Bowel management in paraplegia and tetraplegia Chapter 01 Aug-17 QCG: Heparin-induced thrombocytopenia Chapter 02 Aug-17 QCG: Opioid-induced constipation Chapter 01 Aug-17 Rectal products for constipation Chapter 01 Aug-17 Stimulant laxatives Chapter 01 Aug-17 Tamsulosin Chapter 08 Minor change Aug-17 Urinary tract infections Chapter 06 Aug-17 5HT3 antagonists Chapter 04 Sep-17 Abbreviations Home page Sep-17 Adjuvant analgesics Chapter 05 Sep-17 Alfentanil Chapter 05 Sep-17 www.palliativedrugs.com September 2017 3 of 5 www.palliativedrugs.com PCF updated website monographs continued Monograph Chapter number Date updated Amitriptyline Chapter 04 Sep-17 Anaemia Chapter 09 Sep-17 Antidepressants Chapter 04 Sep-17 Anti-emetics Chapter 04 Sep-17 Anti-epileptics Chapter 04 Sep-17 Antihistaminic antimuscarinic anti-emetics Chapter 04 Sep-17 Artificial saliva Chapter 11 Sep-17 Barrier products Chapter 12 Sep-17 Bisphosphonates Chapter 07 Sep-17 Buprenorphine Chapter 05 Sep-17 Cannabinoids Chapter 04 Sep-17 Carbamazepine Chapter 04 Sep-17 Celecoxib Chapter 05 Sep-17 Codeine Chapter 05 Sep-17 Cranberry juice Chapter 08 Discontinued Sep-17 Diamorphine Chapter 05 Sep-17 Diclofenac Chapter 05 Sep-17 Dihydrocodeine Chapter 05 Sep-17 Domperidone Chapter 04 Sep-17 Drug names Home page Sep-17 Drugs for diabetes mellitus Chapter 07 Sep-17 Drugs for oral inflammation and ulceration Chapter 11 Sep-17 Drugs for pruritus Chapter 26 (new) Minor change Sep-17 Duloxetine Chapter 04 Sep-17 Emollients Chapter 12 Sep-17 Fentanyl Chapter 05 Sep-17 Fentanyl (transmucosal) Chapter 05 Sep-17 Ferrous sulfate Chapter 09 Sep-17 Flurbiprofen Chapter 05 Sep-17 Gabapentin and pregabalin Chapter 04 Sep-17 Getting the most out of PCF Prelims Sep-17 Haloperidol Chapter 04 Sep-17 How PCF is constructed Prelims Sep-17 Hydromorphone Chapter 05 Sep-17 Ibuprofen Chapter 05 Sep-17 Ketorolac Chapter 05 Sep-17 Levetiracetam Chapter 04 Sep-17 Levomepromazine Chapter 04 Sep-17 Magnesium Chapter 09 Sep-17 Methadone Chapter 05 Sep-17 Metolcopramide Chapter 04 Sep-17 Mirtazapine Chapter 04 Sep-17 Monographs available elsewhere Prelims Discontinued Sep-17 Morphine Chapter 05 Sep-17 Nabumetone Chapter 05 Sep-17 Naproxen Chapter 05 Sep-17 Nefopam Chapter 05 Sep-17 Nortriptyline Chapter 04 Discontinued Sep-17 NSAIDs Chapter 05 Sep-17 Octreotide Chapter 07 Sep-17 Olanzapine Chapter 04 Sep-17 Oxcarbazepine Chapter 04 Sep-17 Paracetamol Chapter 05 Sep-17 Phenobarbital Chapter 04 Sep-17 www.palliativedrugs.com September 2017 4 of 5 www.palliativedrugs.com PCF updated